Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease (vol 363, 114370, 2023)

被引：0
|
作者：
Corsi, Sara [1 ]
Scheggi, Simona [2 ]
Pardu, Alessandra [1 ]
Braccagni, Giulia [2 ]
Caruso, Donatella [3 ]
Cioffi, Lucia [2 ]
Diviccaro, Silvia [3 ,4 ]
Gentile, Mauro [1 ]
Fanni, Silvia [1 ]
Stancampiano, Roberto [1 ]
Gambarana, Carla [2 ]
Melcangi, Roberto Cosimo [3 ]
Frau, Roberto [1 ,5 ]
Carta, Manolo [1 ]
机构：
[1] Univ Cagliari, Dept Biomed Sci, Cagliari, CA, Italy
[2] Univ Siena, Dept Mol & Dev Med, Siena, SI, Italy
[3] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, MI, Italy
[4] Lund Univ, Basal Gangl Pathophysiol Unit, Dept Expt Med Sci, Lund, Sweden
[5] Univ Cagliari, Guy Everett Lab, Dept Biomed Sci, Cagliari, Italy
来源：
EXPERIMENTAL NEUROLOGY | 2024年 / 373卷
关键词：
D O I：
10.1016/j.expneurol.2023.114640
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Interferon-γ Involvement in the Neuroinflammation Associated with Parkinson’s Disease and L-DOPA-Induced Dyskinesia
    D. P. Ferrari
    M. Bortolanza
    E. A. Del Bel
    Neurotoxicity Research, 2021, 39 : 705 - 719
  • [32] Interferon-γ Involvement in the Neuroinflammation Associated with Parkinson's Disease and L-DOPA-Induced Dyskinesia
    Ferrari, D. P.
    Bortolanza, M.
    Del Bel, E. A.
    NEUROTOXICITY RESEARCH, 2021, 39 (03) : 705 - 719
  • [33] Immunomodulatory Drugs Alleviate L-Dopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease
    Boi, Laura
    Pisanu, Augusta
    Greig, Nigel H.
    Scerba, Michael T.
    Tweedie, David
    Mulas, Giovanna
    Fenu, Sandro
    Carboni, Ezio
    Spiga, Saturnino
    Carta, Anna R.
    MOVEMENT DISORDERS, 2019, 34 (12) : 1818 - 1830
  • [34] Metformin Inhibits the Development of l-DOPA-Induced Dyskinesia in a Murine Model of Parkinson’s Disease
    Young-Kyoung Ryu
    Hye-Yeon Park
    Jun Go
    Dong-Hee Choi
    Yong-Hoon Kim
    Jung Hwan Hwang
    Jung-Ran Noh
    Tae Geol Lee
    Chul-Ho Lee
    Kyoung-Shim Kim
    Molecular Neurobiology, 2018, 55 : 5715 - 5726
  • [35] L-DOPA-induced dyskinesia
    Derkinderen, P
    Vidailhet, M
    REVUE NEUROLOGIQUE, 2002, 158 : S92 - S101
  • [36] Polymorphisms of Dopamine Receptor Genes and Risk of L-Dopa-Induced Dyskinesia in Parkinson's Disease
    Comi, Cristoforo
    Ferrari, Marco
    Marino, Franca
    Magistrelli, Luca
    Cantello, Roberto
    Riboldazzi, Giulio
    Bianchi, Maria Laura Ester
    Bono, Giorgio
    Cosentino, Marco
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)
  • [37] Dyskinesia: L-dopa-induced and tardive dyskinesia
    Rascol, O
    Fabre, N
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (06) : 313 - 323
  • [38] Cannabidiol and Cannabinoid Compounds as Potential Strategies for Treating Parkinson's Disease and l-DOPA-Induced Dyskinesia
    Ferreira Junior, Nilson Carlos
    dos-Santos-Pereira, Mauricio
    Guimaraes, Francisco Silveira
    Del Bel, Elaine
    NEUROTOXICITY RESEARCH, 2020, 37 (01) : 12 - 29
  • [39] Effects of histone acetyltransferase inhibitors on l-DOPA-induced dyskinesia in a murine model of Parkinson's disease
    Ryu, Young-Kyoung
    Park, Hye-Yeon
    Go, Jun
    Kim, Yong-Hoon
    Hwang, Jung Hwan
    Choi, Dong-Hee
    Noh, Jung-Ran
    Rhee, Myungchull
    Han, Pyung-Lim
    Lee, Chul-Ho
    Kim, Kyoung-Shim
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (09) : 1319 - 1331
  • [40] Beneficial effects of the phytocannabinoid Δ9-THCV in L-DOPA-induced dyskinesia in Parkinson's disease
    Espadas, Isabel
    Keifman, Ettel
    Palomo-Garo, Cristina
    Burgaz, Sonia
    Garcia, Concepcion
    Fernandez-Ruiz, Javier
    Moratalla, Rosario
    NEUROBIOLOGY OF DISEASE, 2020, 141
12345